✦ LIBER ✦
Licensing drugs for diabetes: Surrogate end points are not enough, robust evidence of benefits and harms is needed
✍ Scribed by Richard Lehman, John S Yudkin and Harlan M Krumholz
- Book ID
- 124627867
- Publisher
- BMJ Publishing Group
- Year
- 2010
- Tongue
- English
- Weight
- 505 KB
- Volume
- 341
- Category
- Article
- ISSN
- 0959-8138
- DOI
- 10.2307/20766317
No coin nor oath required. For personal study only.